金沢大学附属病院　リウマチ・膠原病内科

当科の研究業績

2021年

欧文論文

  1. Umehara H, Okazaki K, Kawa S, Takahashi H, Goto H, Matsui S, Ishizaka N, Akamizu T, Sato Y, Kawano M; Research Program for Intractable Disease by the Ministry of Health, Labor and Welfare (MHLW) Japan. The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD. Mod Rheumatol. 31(3): 529-33, 2021 
  2. Nishimura Y, Fajgenbaum DC, Pierson SK, Iwaki N, Nishikori A, Kawano M, Nakamura N, Izutsu K, Takeuchi K, Nishimura MF, Maeda Y, Otsuka F, Yoshizaki K, Oksenhendler E, van Rhee F, Sato Y. Validated international definition of the thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly clinical subtype (TAFRO) of idiopathic multicentric Castleman disease. Am J Hematol. 96(10): 1241-52, 2021 
  3. Mizushima I, Kawano M. Renal involvement in retroperitoneal fibrosis: prevalence, impact and management challenges. Int J Nephrol Renovasc Dis. 14: 279-89, 2021 
  4. Komori T, Inoue D, Izumozaki A, Sugiura T, Terada K, Yoneda N, Toshima F, Yoshida K, Kitao A, Kozaka K, Takahira M, Kawano M, Kobayashi S, Gabata T. Ultrasonography of IgG4-related dacryoadenitis and sialadenitis: Imaging features and clinical usefulness. Mod Rheumatol. roab063, 2021 Online ahead of print 
  5. Waseda Y, Yamada K, Mizuguchi K, Ito K, Watanabe S, Zuka M, Ishizuka T, Malissen M, Malissen B, Kawano M, Matsui S. The pronounced lung lesions developing in LATY136F knock-in mice mimic human IgG4-related lung disease. PLoS One. 16(3): e0247173, 2021 
  6. Kameda H, Takeuchi T, Yamaoka K, Oribe M, Kawano M, Yokoyama M, Pangan AL, Konishi Y, Meerwein S, Tanaka Y. Efficacy and safety of upadacitinib over 84 weeks in Japanese patients with rheumatoid arthritis (SELECT-SUNRISE). Arthritis Res Ther. 23(1): 9, 2021 
  7. Zoshima T, Baba T, Tanabe Y, Ishida Y, Nakatani K, Nagata M, Mukaida N, Kawano M. CCR2- and CCR5-mediated macrophage infiltration contributes to glomerular endocapillary hypercellularity in antibody-induced lupus nephritis. Rheumatology (Oxford). keab825, 2021 
  8. Honda F, Tsuboi H, Ono Y, Abe S, Takahashi H, Ito K, Yamada K, Kawano M, Kondo Y, Asano K, Tanaka M, Malissen M, Malissen B, Matsumoto I, Sumida T. Pathogenic roles and therapeutic potential of the CCL8-CCR8 axis in a murine model of IgG4-related sialadenitis. Arthritis Res Ther. 23(1): 214, 2021 
  9. Mizushima I, Konishi M, Sanada H, Suzuki K, Takeji A, Zoshima T, Hara S, Ito K, Fujii H, Yamada K, Kawano M. Serum IgG4 levels at diagnosis can predict unfavorable outcomes of untreated patients with IgG4-related disease. Sci Rep. 11(1): 13341, 2021 
  10. Mizushima I, Yamano T, Kawahara H, Hibino S, Nishioka R, Zoshima T, Hara S, Ito K, Fujii H, Nomura H, Kawano M. Positive disease-specific autoantibodies have limited clinical significance in diagnosing IgG4-related disease in daily clinical practice. Rheumatology (Oxford). 60(7): 3317-25, 2021 
  11. Kawano M, Sato Y, Fajgenbaum DC. Comment on: HHV-8-negative multicentric Castleman disease patients with serological, histopathological and imaging features of IgG4-related disease: reply. Rheumatology (Oxford). 60(2): e76-7, 2021 
  12. Onoe T, Hara S, Yamada K, Zoshima T, Mizushima I, Ito K, Mori T, Daimon S, Muramoto H, Shimizu M, Iguchi A, Kuma A, Ubara Y, Mitobe M, Tsuruta H, Kishimoto N, Imura J, Konoshita T, Kawano M. Significance of kidney biopsy in autosomal dominant tubulointerstitial kidney disease-UMOD: is kidney biopsy truly nonspecific? BMC Nephrol. 22(1): 1, 2021 
  13. Hosokawa K, Aoki G, Ohata K, Takamatsu H, Nakagawa N, Imi T, Iwaki N, Ito K, Kawano M, Nakamura T, Takamori M, Ishiyama K, Kondo Y, Yamazaki H, Nakao S. Effectiveness of hyperbaric oxygen therapy for virus-associated hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation. Int J Hematol. 114(1): 109-15, 2021 
  14. Fujisawa Y, Mizushima I, Yamada K, Yamamoto M, Saeki T, Matsui S, Tsuge S, Hara S, Ito K, Fujii H, Takahashi H, Nomura H, Kawa S, Kawano M. Hypocomplementemia is related to elevated serum levels of IgG subclasses other than IgG4 in IgG4-related kidney disease. Mod Rheumatol. 31(1): 241-8, 2021 
  15. Saeki T, Nagasawa T, Ubara Y, Taniguchi Y, Yanagita M, Nishi S, Nagata M, Yamaguchi Y, Saito T, Nakashima H, Kawano M. Validation of the 2019 ACR/EULAR criteria for IgG4-related disease in a Japanese kidney disease cohort: a multicentre retrospective study by the IgG4-related kidney disease working group of the Japanese Society of Nephrology. Ann Rheum Dis. 80(7): 956-7, 2021 
  16. Kawano M, Hara S, Yachie A, Inoue D, Sato Y, Fajgenbaum DC. HHV-8-negative multicentric Castleman disease patients with serological, histopathological and imaging features of IgG4-related disease. Rheumatology (Oxford). 60(1): e3-4, 2021 
  17. Saeki T, Kawano M, Nagasawa T, Ubara Y, Taniguchi Y, Yanagita M, Nishi S, Nagata M, Hisano S, Yamaguchi Y, Nomura H, Saito T, Nakashima H. Validation of the diagnostic criteria for IgG4-related kidney disease (IgG4-RKD) 2011, and proposal of a new 2020 version. Clin Exp Nephrol. 25(2): 99-109, 2021 
  18. Nakashima A, Horita S, Matsunaga T, Inoue R, Zoshima T, Mizushima I, Hara S, Ito K, Fujii H, Nomura H, Kawano M. Factors contributing to discrepant estimated glomerular filtration values measured by creatinine and cystatin C in patients with rheumatoid arthritis. Sci Rep. 11(1): 9884, 2021 
  19. Ohtsubo K, Yamashita K, Yanagimura N, Suzuki C, Tanimoto A, Nishiyama A, Takeuchi S, Iwaki N, Kawano M, Izumozaki A, Inoue D, Gabata T, Ikeda H, Watanabe M, Yano S. Multiple malignant lymphomas of the bile duct developing after spontaneous regression of an autoimmune pancreatitis-like mass. Intern Med. 60(3): 409-15, 2021 
  20. Takahashi Y, Mizushima I, Konishi M, Kawahara H, Sanada H, Suzuki K, Takeji A, Hara S, Ito K, Fujii H, Kawano M. Involvement of two or more sets of lacrimal glands and/or major salivary glands is related to greater systemic disease activity due to multi-organ involvement in IgG4-related dacryoadenitis/sialadenitis. Mod Rheumatol. 31(6): 1164-70, 2021 
  21. Saeki T, Kawano M, Nagasawa T, Ubara Y, Taniguchi Y, Yanagita M, Nishi S, Nagata M, Hisano S, Yamaguchi Y, Nomura H, Saito T, Nakashima H. Correction to: Validation of the diagnostic criteria for IgG4‑related kidney disease (IgG4‑RKD) 2011, and proposal of a new 2020 version. Clin Exp Nephrol. 25(4): 443-4, 2021 
  22. Nishioka R, Hara S, Kawahara H, Ito K, Mizushima I, Hirata M, Nagata M, Kawano M. Glomerulonephritis with severe nephrotic syndrome induced by immune complexes composed of galactose-deficient IgA1 in primary Sjögren's syndrome: a case report. BMC Nephrol. 22(1): 108, 2021 
  23. Takahashi Y, Hara S, Hoshiba R, Hibino S, Ito K, Zoshima T, Suzuki Y, Inoue D, Mizushima I, Fujii H, Kawano M. Pneumonia and central nervous system infection caused by reactivation of varicella-zoster virus in a living-donor kidney transplantation patient: case report and review of the literature. CEN Case Rep. 10(3): 370-7, 2021 
  24. Miyanaga T, Mizuguchi K, Hara S, Zoshima T, Inoue D, Nishioka R, Mizushima I, Ito K, Fuji H, Yamada K, Sato Y, Yanagita M, Kawano M. Tertiary lymphoid tissue in early-stage IgG4-related tubulointerstitial nephritis incidentally detected with a tumor lesion of the ureteropelvic junction: a case report. BMC Nephrol. 22(1): 34, 2021 
  25. Horita S, Zoshima T, Hara S, Koichi M, Hirayama S, Suzuki K, Nakashima A, Kawano M. Antiphospholipid antibody syndrome-associated renal thrombotic microangiopathy improved not with rivaroxaban but with warfarin in a systemic lupus erythematosus patient without lupus nephritis. CEN Case Rep. 10(3): 409-13, 2021 

2020年

欧文論文

  1. Wallace ZS, Naden RP, Chari S, Choi HK, Della-Torre E, Dicaire JF, Hart PA, Inoue D, Kawano M, Khosroshahi A, Lanzillotta M, Okazaki K, Perugino CA, Sharma A, Saeki T, Schleinitz N, Takahashi N, Umehara H, Zen Y, Stone JH; Members of the ACR/EULAR IgG4-RD Classification Criteria Working Group. The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease. Ann Rheum Dis. 79(1): 77-87, 2020 
  2. Wallace ZS, Naden RP, Chari S, Choi H, Della-Torre E, Dicaire JF, Hart PA, Inoue D, Kawano M, Khosroshahi A, Kubota K, Lanzillotta M, Okazaki K, Perugino CA, Sharma A, Saeki T, Sekiguchi H, Schleinitz N, Stone JR, Takahashi N, Umehara H, Webster G, Zen Y, Stone JH; American College of Rheumatology/European League Against Rheumatism IgG4-Related Disease Classification Criteria Working Group. The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease. Arthritis Rheumatol. 72(1): 7-19, 2020 
  3. Kameda H, Takeuchi T, Yamaoka K, Oribe M, Kawano M, Zhou Y, Othman AA, Pangan AL, Kitamura S, Meerwein S, Tanaka Y. Efficacy and safety of upadacitinib in Japanese patients with rheumatoid arthritis (SELECT-SUNRISE): a placebo-controlled phase IIb/III study. Rheumatology (Oxford). 59(11): 3303-13, 2020 
  4. Nishioka R, Kawano M. Tongue ulceration from cytomegalovirus infection. N Engl J Med. 383(1): 67, 2020 
  5. Zoshima T, Suzuki K, Suzuki F, Hara S, Mizuguchi K, Ito K, Mizushima I, Fujii H, Nomura H, Kawano M. ANCA-associated nephritis without crescent formation has atypical clinicopathological features: a multicenter retrospective study. Clin Exp Nephrol. 24(11): 999-1006, 2020 
  6. Mizushima I, Tsuge S, Fujisawa Y, Hara S, Suzuki F, Ito K, Fujii H, Yamada K, Kawano M. Different factors underlie recurrent and de novo organ involvement in immunoglobulin G4-related disease. Rheumatology (Oxford). 59(3): 513-8, 2020 
  7. Mizushima I, Yamano T, Kawahara H, Hibino S, Nishioka R, Zoshima T, Hara S, Ito K, Fujii H, Nomura H, Kawano M. Positive disease-specific autoantibodies have limited clinical significance in diagnosing IgG4-related disease in daily clinical practice. Rheumatology (Oxford). keaa783, 2020 
  8. Nakamura T, Satoh-Nakamura T, Nakajima A, Kawanami T, Sakai T, Fujita Y, Iwao H, Miki M, Masaki Y, Okazaki T, Ishigaki Y, Kawano M, Yamada K, Matsui S, Saeki T, Kamisawa T, Yamamoto M, Hamano H, Origuchi T, Hirata S, Tanaka Y, Tsuboi H, Sumida T, Okazaki K, Tanaka M, Chiba T, Mimori T, Umehara H. Impaired expression of innate immunity-related genes in IgG4-related disease: A possible mechanism in the pathogenesis of IgG4-RD. Mod Rheumatol. 30(3): 551-7, 2020 
  9. Suda T, Zoshima T, Takeji A, Suzuki Y, Mizushima I, Yamada K, Nakashima A, Yachie A, Kawano M. Elderly-onset Still's disease complicated by macrophage activation syndrome: A case report and review of the literature. Intern Med. 59(5): 721-8, 2020 
  10. Kawahara H, Nakashima A, Zoshima T, Kawano M. Contribution of HLA-DRB1 * 09: 01 allele to development of minocycline induced antineutrophil cytoplasmic antibody (ANCA)-associated cutaneous vasculitis: report of two cases. Mod Rheumatol Case Rep. 4(2): 267-71, 2020 
  11. Fujisawa Y, Hara S, Zoshima T, Maekawa N, Inoue D, Sasaki M, Gamou T, Nagata Y, Hayashi K, Takeji A, Ito K, Mizushima I, Fujii H, Kawano M. Fulminant myocarditis and pulmonary cavity lesion induced by disseminated mucormycosis in a chronic hemodialysis patient: Report of an autopsied case. Pathol Int. 70(8): 557-62, 2020 
  12. Acar-Denizli N, Horváth IF, Mandl T, Priori R, Vissink A, Hernandez-Molina G, Armagan B, Praprotnik S, Sebastian A, Bartoloni E, Rischmueller M, Pasoto SG, Nordmark G, Nakamura H, Fernandes Moça Trevisani V, Retamozo S, Carsons SE, Maure-Noia B, Sánchez-Berná I, López-Dupla M, Fonseca-Aizpuru E, Melchor Díaz S, Vázquez M, Díaz Cuiza PE, de Miguel Campo B, Ng WF, Rasmussen A, Dong X, Li X, Baldini C, Seror R, Gottenberg JE, Kruize AA, Sandhya P, Gandolfo S, S. Kwok SK, Kvarnstrom M, Solans R, Sene D, Suzuki Y, Isenberg DA, Valim V, Hofauer B, Giacomelli R, Devauchelle-Pensec V, Atzeni F, Gheita TA, Morel J, Izzo R, Kalyoncu U, Szántó A, Olsson P, Bootsma H, Ramos-Casals M, Kostov B, Brito-Zerón P, for the Sjögren Big Data Consortium. Systemic phenotype related to primary Sjögren's syndrome in 279 patients carrying isolated anti-La/SSB antibodies. Clin. Exp. Rheumatol. 38(4)(Suppl.126): 85-94, 2020  

2019年

欧文論文

  1. Mizushima I, Tsuge S, Fujisawa Y, Hara S, Suzuki F, Ito K, Fujii H, Yamada K, Kawano M. Different factors underlie recurrent and de novo organ involvement in immunoglobulin G4-related disease. Rheumatology (Oxford). 2019 Aug 2. pii: kez321. [Epub ahead of print]
  2. Yoshida M, Zoshima T, Hara S, Mizushima I, Fujii H, Yamada K, Sato Y, Harada K, Kawano M. A long-term survival after surgical treatment for atypical aortic coarctation complicating Takayasu arteritis with inactive disease at the diagnosis: An appropriately treated autopsy case. Intern Med. 58(15): 2241-6, 2019
  3. Yoshida K, Takahashi N, King BF, Kawashima A, Harris PC, Cornell LD, Cornec-Le Gall E, Inoue D, Mizushima I, Kawano M, Thervet E, de Cotret PR, Torres VE. Multiple unilateral subcapsular cortical hemorrhagic cystic disease of the kidney: CT and MRI findings and clinical characteristic. Eur Radiol. 29(9): 4843-50, 2019
  4. Nakamura T, Satoh-Nakamura T, Nakajima A, Kawanami T, Sakai T, Fujita Y, Iwao H, Miki M, Masaki Y, Okazaki T, Ishigaki Y, Kawano M, Yamada K, Matsui S, Saeki T, Kamisawa T, Yamamoto M, Hamano H, Origuchi T, Hirata S, Tanaka Y, Tsuboi H, Sumida T, Okazaki K, Tanaka M, Chiba T, Mimori T, Umehara H. Impaired expression of innate immunity-related genes in IgG4-related disease: A possible mechanism in the pathogenesis of IgG4-RD. Mod Rheumatol. 1-7, 2019 Jul 11
  5. Zoshima T, Hara S, Yamagishi M, Pastan I, Matsusaka T, Kawano M, Nagata M. Possible role of complement factor H in podocytes in clearing glomerular subendothelial immune complex deposits. Sci Rep. 9(1): 7857, 2019
  6. Ito K, Hara S, Yamada K, Zoshima T, Mizushima I, Fujii H, Miyazaki R, Kawai Y, Yachie A, Nagata M, Izui S, Yamagishi M, Kawano M. A case report of crystalline light chain inclusion-associated kidney disease affecting podocytes but without Fanconi syndrome: A clonal analysis of pathological monoclonal light chain. Medicine (Baltimore). 98(5): e13915, 2019
  7. Wallace ZS, Zhang Y, Perugino CA, Naden R, Choi HK, Stone JH; ACR/EULAR IgG4-RD Classification Criteria Committee. Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts. Ann Rheum Dis. 78(3): 406-12, 2019
  8. Yamada K, Mizushima I, Kawano M. New insights into the pathophysiology of IgG4-related disease and markers of disease activity. Expert Rev Clin Immunol. 15(3): 231-9, 2019
  9. Mizushima I, Kasashima S, Fujinaga Y, Kawano M, Ishizaka N. IgG4-related periaortitis/periarteritis: An under-recognized condition that is potentially life-threatening. Mod Rheumatol. 29(2): 240-50, 2019
  10. Kawakami T, Mizushima I, Yamada K, Fujii H, Ito K, Yasuno T, Izui S, Yamagishi M, Huard B, Kawano M. Abundant a proliferation-inducing ligand (APRIL)-producing macrophages contribute to plasma cell accumulation in immunoglobulin G4-related disease. Nephrol Dial Transplant. 34(6): 960-9, 2019
  11. Takeji A, Yamada K, Inoue D, Mizushima I, Hara S, Ito K, Fujii H, Nakajima K, Mizutomi K, Yamagishi M, Kawano M. A case of IgG4-related kidney disease with predominantly unilateral renal atrophy. CEN Case Rep. 8(1): 8-13, 2019
  12. Kawano M, Saeki T, Nakashima H. IgG4-related kidney disease and retroperitoneal fibrosis: An update. Mod Rheumatol. 29(2): 231-9, 2019

2018年

欧文論文

  1. Inoue K, Okubo T, Kato T, Shimamura K, Sugita T, Kubota M, Kanaya K, Yamachika D, Sato M, Inoue D, Harada K, Kawano M. IgG4-related stomach muscle lesion with a renal pseudotumor and multiple renal rim-like lesions： a rare manifestation of IgG4-related disease. Mod Rheumatol. 28(1): 188-92, 2018
  2. Mizushima I, Yamada K, Harada K, Matsui S, Saeki T, Kondo S, Takahira M, Waseda Y, Hamaguchi Y, Fujii H, Yamagishi M, Kawano M. Diagnostic sensitivity of cutoff values of IgG4-positive plasma cell number and IgG4-positive/CD138-positive cell ratio in typical multiple lesions of patients with IgG4-related disease. Mod Rheumatol. 28(2): 293-9, 2018
  3. Aizu M, Mizushima I, Nakazaki S, Nakashima A, Kato T, Murayama T, Kato S, Katsuki Y, Ogane K, Fujii H, Yamada K, Nomura H, Yachie A, Yamagishi M, Kawano M. Changes in serum interleukin-6 levels as possible predictor of efficacy of tocilizumab treatment in rheumatoid arthritis. Mod Rheumatol. 28(4): 592-8, 2018
  4. Notohara K, Kamisawa T, Uchida K, Zen Y, Kawano M, Kasashima S, Sato Y, Shiokawa M, Uehara T, Yoshifuji H, Hayashi H, Inoue K, Iwasaki K, Kawano H, Matsubayashi H, Moritani Y, Murakawa K, Oka Y, Tateno M, Okazaki K, Chiba T. Gastrointestinal manifestation of immunoglobulin G4-related disease： clarification through a multicenter survey. J Gastroenterol. 53(7): 845-53, 2018
  5. Suzuki Y, Fujii H, Nomura H, Mizushima I, Yamada K, Yamagishi M, Kawano M. Impact of double positive for anti-centromere and anti-SSa/Ro antibodies on clinicopathological characteristics of primary Sjögren's syndrome： a retrospective cohort study. Mod Rheumatol. 28(5): 872-8, 2018
  6. Sumida T, Azuma N, Moriyama M, Takahashi H, Asashima H, Honda F, Abe S, Ono Y, Hirota T, Hirata S, Tanaka Y, Shimizu T, Nakamura H, Kawakami A, Sano H, Ogawa Y, Tsubota K, Ryo K, Saito I, Tanaka A, Nakamura S, Takamura E, Tanaka M, Suzuki K, Takeuchi T, Yamakawa N, Mimori T, Ohta A, Nishiyama S, Yoshihara T, Suzuki Y, Kawano M, Tomiita M, Tsuboi H. Clinical practice guideline for Sjögren's syndrome 2017. Mod Rheumatol. 28(3): 383-408, 2018
  7. Iguchi T, Takaori K, Mii A, Sato Y, Suzuki Y, Yoshifuji H, Seno H, Ogawa O, Omori K, Bessho K, Kondo S, Yoshizaki T, Nakashima H, Saito T, Mimori T, Haga H, Kawano M, Yanagita M. Glucocorticoid receptor expression in resident and hematopoietic cells in IgG4-related disease. Mod Pathol. 31(6)： 890-9, 2018
  8. Wallace ZS, Khosroshahi A, Carruthers MD, Perugino CA, Choi H, Campochiaro C, Culver EL, Cortazar F, Della-Torre E, Ebbo M, Fernandes A, Frulloni L, Hart P, Karadag O, Kawa S, Kawano M, Kim MH, Lanzillotta M, Matsui S, Okazaki K, Ryu JH, Saeki T, Schleinitz N, Tanasa P, Umehara H, Webster G, Zhang W, Stone JH. An international multispecialty validation study of the IgG4-related disease responder index. Arthritis Care Res (Hoboken). 70(11): 1671-8, 2018
  9. Hara S, Hirata M, Ito K, Mizushima I, Fujii H, Yamada K, Nagata M, Kawano M. Post-infectious acute glomerulonephritis with podocytopathy induced by parvovirus B19 infection. Pathol Int. 6(83): 190-5, 2018
  10. Watanabe S, Saeki K, Waseda Y, Murata A, Takato H, Ichikawa Y, Yasui M, Kimura H, Hamaguchi Y, Matsushita T, Yamada K, Kawano M, Furuichi K, Wada T, Kasahara K. Lung cancer in connective tissue disease-associated interstitial lung disease： clinical features and impact on outcomes. J Thorac Dis. 10(2): 799-807, 2018
  11. Horinouchi T, Nozu K, Yamamura T, Minamikawa S, Omori T, Nakanishi K, Fujimura J, Ashida A, Kitamura M, Kawano M, Shimabukuro W, Kitabayashi C, Imafuku A, Tamagaki K, Kamei K, Okamoto K, Fujinaga S, Oka M, Igarashi T, Miyazono A, Sawanobori E, Fujimaru R, Nakanishi K, Shima Y, Matsuo M, Ye MJ, Nozu Y, Morisada N, Kaito H, Iijima K. Detection of splicing abnormalities and genotype-phenotype correlation in X-linked Alport syndrome. J Am Soc Nephrol. 29(8): 2244-54, 2018
  12. Yamada K, Zuka M, Ito K, Mizuguchi K, Kakuchi Y, Onoe T, Suzuki Y, Yamagishi M, Izui S, Malissen M, Malissen B, Kawano M. LatY136F knock-in mouse model for human IgG4-related disease. PLoS One. 13(6): e0198417, 2018
  13. Shirakashi M, Yoshifuji H, Kodama Y, Chiba T, Yamamoto M, Takahashi H, Uchida K, Okazaki K, Ito T, Kawa S, Yamada K, Kawano M, Hirata S, Tanaka Y, Moriyama M, Nakamura S, Kamisawa T, Matsui S, Tsuboi H, Sumida T, Shibata M, Goto H, Sato Y, Yoshino T, Mimori T. Factors in glucocorticoid regimens associated with treatment response and relapses of IgG4-related disease： a multicentre study. Sci Rep. 8(1): 10262, 2018
  14. Kawashiri SY, Origuchi T, Umeda M, Nishino A, Shimizu T, Fukui S, Koga T, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Maeda T, Kawano M, Yamamoto M, Izumi Y, Kawakami A. Association of serum levels of fibrosis-related biomarkers with disease activity in patients with IgG4-related disease. Arthritis Res Ther. 20(1): 277, 2018
  15. Brito-Zerón P, Acar-Denizli N, Ng WF, Zeher M, Rasmussen A, Mandl T, Seror R, Li X, Baldini C, Gottenberg JE, Danda D, Quartuccio L, Priori R, Hernandez-Molina G, Armagan B, Kruize AA, Kwok SK, Kvarnström M, Praprotnik S, Séne D, Bartoloni E, Solans R, Rischmueller M, Suzuki Y, Isenberg DA, Valim V, Wiland P, Nordmark G, Fraile G, Bootsma H, Nakamura T, Giacomelli R, Devauchelle-Pensec V, Knopf A, Bombardieri M, Trevisani VF, Hammenfors D, Pasoto SG, Retamozo S, Gheita TA, Atzeni F, Morel J, Vollenveider C, Horvath IF, Sivils KL, Olsson P, De Vita S, Sánchez-Guerrero J, Kilic L, Wahren-Herlenius M, Mariette X, Ramos-Casals M, Sjögren Big Data Consortium. How immunological profile drives clinical phenotype of primary Sjögren's syndrome at diagnosis： analysis of 10, 500 patients (Sjögren Big Data Project). Clin Exp Rheumatol. 36(3)(Suppl. 112): 102-12, 2018

和文論文

  1. 川野　充弘・唐島　成宙・松井　祥子・赤水　尚史，IgG4関連疾患，ここが知りたい!内分泌疾患診療ハンドブック　Ver. 2：355-63，2018
  2. 原　怜史・鈴木　康倫・川野　充弘，シェーグレン症候群の診断と治療マニュアル改訂第3版2腺外症状　2） 腎病変，診断と治療社　：123-8，2018
  3. 原　怜史・川野　充弘，IgG4関連疾患と線維化，腎臓内科・泌尿器科　7（4）：368-75，2018
  4. 鈴木　康倫・川野　充弘，シェーグレン症候群に伴う腎障害の診断と治療，リウマチ科　59（2）：152-7，2018
  5. 鈴木　康倫・川野　充弘，シェーグレン症候群. 今日の診療のために ガイドライン
    外来診療，2018日経メディカル開発　：493-5，2018
  6. 鈴木　康倫，講演要旨（内科系リウマチ専門医からみた関節リウマチ診療－鑑別診断の重要性－），AJU曲水　102号（日本リウマチ友の会石川支部　会報）：6-7，2018
  7. 鈴木　康倫・西岡　亮・竹治　明梨・堀田　成人・中島　昭勝，口唇小唾液腺生検からみたシェーグレン症候群の診療：2年間52例の検討，石川県立中央病院雑誌　40：5-9，2018
  8. 水島　伊知郎・笠島　里美・藤永　康成・能登原　憲司・佐伯　敬子・全　陽・井上　大・山本　元久・笠島　史成・松本　康・網谷　英介・川　茂幸・川野　充弘・石坂　信和，IgG4関連動脈周囲炎/後腹膜線維症の臨床像の解析と本疾患に対する特異的診断基準，J Jpn Coll Angiol 　58：117-29，2018
  9. 水島　伊知郎・川野　充弘，IgG4関連後腹膜線維症の臨床像，リウマチ科　60（4）：387-92，2018

2017年

欧文論文

  1. Yamada K, Zoshima T, Ito K, Mizushima I, Hara S, Horita S, Nuka H, Hamano R, Fujii H, Yamagishi M, Kawano M. A case developing minimal change disease during the course of IgG4-related disease. Mod Rheumatol. 27(4): 712-5, 2017
  2. Tanaka N, Muro Y, Suzuki Y, Nishiyama S, Takada K, Sekiguchi M, Hashimoto N, Ohmura K, Shimoyama K, Saito I, Kawano M, Akiyama M. Anticentromere antibody-positive primary Sjögren's syndrome: Epitope analysis of a subset of anticentromere antibodypositive patients. Mod Rheumatol. 27(1): 115-21, 2017
  3. Nakashima H, Kawano M, Saeki T, Ubara Y, Hisano S, Nagata M, Zen Y, Yanagita M, Yamaguchi Y, Nishi S, Saito T. Estimation of the number of histological diagnosis for IgG4-related kidney disease referred to the data obtained from the Japan Renal Biopsy Registry (J-RBR) questionnaire and cases reported in the Japanese Society of Nephrology Meetings. Clin Exp Nephrol. 21(1): 97-103, 2017
  4. Masaki Y, Matsui S, Saeki T, Tsuboi H, Hirata S, Izumi Y, Miyashita T, Fujikawa K, Dobashi H, Susaki K, Morimoto H, Takagi K, Kawano M, Origuchi T, Wada Y, Takahashi N, Horikoshi M, Ogishima H, Suzuki Y, Kawanami T, Kawanami Iwao H, Sakai T, Fujita Y, Fukushima T, Saito M, Suzuki R, Morikawa Y, Yoshino T, Nakamura S, Kojima M, Kurose N, Sato Y, Tanaka Y, Sugai S, Sumida T. A multicenter phase II prospective clinical trial of glucocorticoid for patients with untreated IgG4-related disease. Mod Rheumatol. 27(5): 849-54, 2017
  5. Umehara H, Okazaki K, Nakamura T, Satoh-Nakamura T, Nakajima A, Kawano M, Mimori T, Chiba T. Current approach to the diagnosis of IgG4-related disease-Combination of comprehensive diagnostic and organ-specific criteria. Mod Rheumatol. 27(3): 381-91, 2017
  6. Umehara H, Okazaki K, Kawano M, Mimori T, Chiba T. How to diagnose IgG4-related disease. Ann Rheum Dis. 76(11): e46, 2017
  7. Taniguchi Y, Kawano M, Zen Y, Aoyama N, Suehiro F, Terada Y. Immunoglobulin G4-related disease associated with extensive granulomatous changes. Rheumatology (Oxford). 56(8): 1430-3, 2017
  8. Iwaki N, Gion Y, Kondo E, Kawano M, Masunari T, Moro H, Nikkuni K, Takai K, Hagihara M, Hashimoto Y, Yokota K, Okamoto M, Nakao S, Yoshino T, Sato Y. Elevated serum interferon γ-induced protein 10 kDa is associated with TAFRO syndrome. Sci Rep. 7: 42316, 2017
  9. Numata T, Tsumoto K, Yamada K, Kurokawa T, Hirose S, Nomura H, Kawano M, Kurachi Y, Inoue R, Mori Y. Integrative Approach with Electrophysiological and Theoretical Methods Reveals a New Role of S4 Positively Charged Residues in PKD2L1 Channel Voltage-Sensing. Sci Rep. 7(1): 9760, 2017
  10. Yamada K, Yamamoto M, Saeki T, Mizushima I, Matsui S, Fujisawa Y, Hara S, Takahashi H, Nomura H, Kawa S, Kawano M. New clues to the nature of immunoglobulin G4-related disease: a retrospective Japanese multicenter study of baseline clinical features of 334 cases. Arthritis Res Ther. 19(1): 262, 2017
  11. Okada M, Fujii H, Suga Y, Morito S, Okada M, Nishigami J, Kawano M, Shimada T, Sai Y. Drug interaction between methotrexate and salazosulfapyridine in Japanese patients with rheumatoid arthritis. J Pharm Health Care Sci. 3: 7, 2017
  12. Nagata M, Kobayashi N, Hara S. Focal segmental glomerulosclerosis; why does it occur segmentally? Pflugers Arch. 469(7-8): 983-988, 2017

和文論文

  1. 川野　充弘・全　陽・佐藤　康晴・井上　大，よくわかるIgG4関連疾患，よくわかるIgG4関連疾患　単行本，2017
  2. 川野　充弘，全身性硬化症（強皮症腎），腎生検病理アトラス　改訂版　：273-6，2017
  3. 伊藤　清亮・山田　和徳，関節リウマチにおける糖鎖制御異常，アレルギーの臨床　37（5），2017
  4. 鈴木　康倫・川野　充弘・厚生労働省科学研究費補助金難治性疾患等政策研究事業 自己免疫疾患に関する調査研究班（研究代表者）住田　孝之，シェーグレン症候群診療ガイドライン2017年版，シェーグレン症候群診療ガイドライン2017年版　：51-5，72-9，112-3，2017

2016年

欧文論文

  1. Mizushima I, Yamamoto M, Inoue D, Nishi S, Taniguchi Y, Ubara Y, Matsui S, Yasuno T, Nakashima H, Takahashi H, Yamada K, Nomura H, Yamagishi M, Saito T, Kawano M. Factors related to renal cortical atrophy development after glucocorticoid therapy in IgG4-related kidney disease: a retrospective multicenter study. Arthritis Res Ther. 18(1): 273, 2016
  2. Onoe T, Yamada K, Mizushima I, Ito K, Kawakami T, Daimon S, Muramoto H, Konoshita T, Yamagishi M, Kawano M. Hints to the diagnosis of uromodulin kidney disease. Clin Kidney J. 9(1): 69-75, 2016
  3. Hara S, Kawano M, Mizushima I, Harada K, Takata T, Saeki T, Ubara Y, Sato Y, Nagata M. Distribution and components of interstitial inflammation and fibrosis in IgG4-related kidney disease : Analysis of autopsy specimens. Hum Pathol. 55: 164-73, 2016
  4. Hara S, Kawano M, Mizushima I, Yamada K, Fujita K, Harada K, Matsumura M, Yamagishi M, Sato Y, Yamaguchi Y, Nakanuma Y, Nagata M. A condition closely mimicking IgG4-related disease despite the absence of serum IgG4 elevation and IgG4-positive plasma cell infiltration. Mod Rheumatol. 26(5): 784-9, 2016
  5. Mizushima I, Inoue D, Kawano M. Retroperitoneal fibrosis/periaortitis and hydronephrosis. IgG4-Related Kidney Disease. Japan: Springer. 159-72, 2016
  6. Hara S, Kawano M, Mizushima I, Harada K, Takata T, Saeki T, Ubara Y, Sato Y, Nagata M. Characteristic distribution of inflammatory lesions in IgG4-related kidney disease: findings from autopsy case series. IgG4-Related Kidney Disease. Japan: Springer. 187-92, 2016
  7. Kawano M, Yamada K. Diagnosis of IgG4-related kidney disease. IgG4-Related Kidney Disease. Japan: Springer 193-202, 2016
  8. Kawano M, Hara S, Ubara Y. Differential diagnosis（s1）: ANCA associated vasculitis. IgG4-Related Kidney Disease. Japan: Springer. 251-60, 2016
  9. Kawano M, Yamada K. IgG4-related kidney disease and IgG4-related retroperitoneal fibrosis. Semin Liver Dis. 36(3): 283-90, 2016
  10. Saeki T, Kawano M, Mizushima I, Yamamoto M, Wada Y, Ubara Y, Nakashima H, Ito T, Yamazaki H, Narita I, Saito T. Recovery of renal function after glucocorticoid therapy for IgG4-related kidney disease with renal dysfunction. Clin Exp Nephrol. 20(1): 87-93, 2016
  11. Zoshima T, Yamada K, Hara S, Mizushima I, Yamagishi M, Harada K, Sato Y, Kawano M. Multicentric castleman disease with tubulointerstitial nephritis mimicking IgG4-related disease: two case reports. Am J Surg Pathol. 40(4): 495-501, 2016
  12. Saeki T, Kawano M. Dose IgG4-related disease have an autoimmune basis? in : saito T, et al. editors. IgG4-Related Kidney Disease. Japan: Springer. 55-64, 2016
  13. Inoue D, Zen Y, Kawano M, Matui O, Gabata T. Imaging findings. In : Saito T, et al. editors. IgG4-Related Kidney Disease. Japan: Springer. 97-104, 2016
  14. Nagata M, Hara S. Characteristic tubulointerstitial nephritis in IgG4-Related kidney disease. IgG4-Related Kidney Disease. Japan: Springer. 105-14, 2016
  15. Yamaguchi Y, Hara S, Kawano M. Differential diagnosis of IgG4-related tubulointerstitial nephritis: an overview. IgG4-Related Kidney Disease. Japan: Springer. 237-50, 2016
  16. Zoshima T, Kawano M, Hara S, Nagata M. Differential Diagnosis (2): Castleman Disease. IgG4-Related Kidney Disease. Japan: Springer. 261-70, 2016
  17. Kakuchi Y, Yamada K, Ito K, Hara S, Fujii H, Yamagishi M, Kawano M. Analysis of IgG4-positive clones in affected organs of IgG4-related disease.Mod Rheumatol. 26(6): 923-928, 2016
  18. Takashima Y, Keino-Masu K, Yashiro H, Hara S, Suzuki T, van Kuppevelt TH, Masu M, Nagata M. Heparan sulfate 6-O-endosulfatases, Sulf1 and Sulf2, regulate glomerular integrity by modulating growth factor signaling. Am J Physiol Renal Physiol. 310(5): F395-408, 2016

和文論文

  1. 川野　充弘・鈴木　康倫，シェーグレン症候群の腎病変，リウマチ科　56（5）：458-64, 2016
  2. 川野　充弘，特集「IgG4関連疾患の病因・病態を考える」3）IgG4関連腎臓病から，分子リウマチ治療　9（1）：8-12，2016
  3. 伊藤　清亮・山田　和徳，関節リウマチとPAD，看護技術　62（4）：26-9，2016
  4. 伊藤　清亮・山田　和徳，リウマチ性多発筋痛症と巨細胞性動脈炎，Medical Practice　33（7），2016
  5. 水島　伊知郎・川野　充弘，あの病態ってもしや…？ダイジェスト“IgG4関連疾患”　腎病変・泌尿器病変（前立腺病変など），診断と治療　104（4）：469-75，2016
  6. 水島　伊知郎・川野　充弘，IgG4関連疾患による水腎症，リウマチ科　56（2）：157-64，2016

2015年

欧文論文

  1. Kobayashi N, Ueno T, Ohashi K, Yamashita H, Takahashi Y, Sakamoto K, Manabe S, Hara S, Takashima Y, Dan T, Pastan I, Miyata T, Kurihara H, Matsusaka T, Reiser J, Nagata M. Podocyte injury-driven intracapillary plasminogen activator inhibitor type 1 accelerates podocyte loss via uPAR-mediated β1-integrin endocytosis. Am J Physiol Renal Physiol. 308(6): 614-26, 2015
  2. Hara S, Kobayashi N, Sakamoto K, Ueno T, Manabe S, Takashima Y, Hamada J, Pastan I, Fukamizu A, Matsusaka T, Nagata M. Podocyte injury-driven lipid peroxidation accelerates the infiltration of glomerular foam cells in focal segmental glomerulosclerosis. Am J Pathol. 185(8): 2118-31, 2015
  3. Mori K, Yamada K, Konno T, Inoue D, Uno Y, Watanabe M, Okuda M, Oe K, Kawano M, Yamagishi M. Pericardial involvement in IgG4-related disease. Intern Med. 54(10): 1231-5, 2015
  4. Nakajima A, Masaki Y, Nakamura T, Kawanami T, Ishigaki Y, Takegami T, Kawano M, Yamada K, Tsukamoto N, Matsui S, Saeki T, Okazaki K, Kamisawa T, Miyashita T, Yakushijin Y, Fujikawa K, Yamamoto M, Hamono H, Origuchi T, Hirata S, Tsuboi H, Sumida T, Morimoto H, Sato T, Iwao H, Miki M, Sakai T, Fujita Y, Tanaka M, Fukushima T, Okazaki T, Umehara H. Decreased expression of innate immunity-related genes in peripheral blood mononuclear cells from patients with IgG4-related disease. PLoS One. 10(5): e0126582, 2015
  5. Kawano M, Suzuki Y, Yamada K, Mizushima I, Matsumura M, Nakajima K, Yamagishi M, Yamaguchi Y. Primary Sjögren’ s syndrome with chronic tubulointerstitial nephritis and lymphadenopathy mimicking IgG4-related disease. Mod Rheumatol. 25(4): 637-41, 2015
  6. Buelli S, Perico L, Galbusera M, Abbate M, Morigi M, Novelli R, Gagliardini E, Tentori C, Rottoli D, Sabadini E, Saito T, Kawano M, Saeki T, Zoja C, Remuzzi G, Benigni A. Mitochondrial-dependent autoimmunity in membranous nephropathy of IgG4-related disease. EBioMedicine. 2(5): 456-66, 2015
  7. Khosroshahi A, Wallace ZS, Crowe JL, Akamizu T, Azumi A, Carruthers MN, Chari ST, Della-Torre E, Frulloni L, Goto H, Hart PA, Kamisawa T, Kawa S, Kawano M, Kim MH, Kodama Y, Kubota K, Lerch MM, Löhr M, Masaki Y, Matsui S, Mimori T, Nakamura S, Nakazawa T, Ohara H, Okazaki K, Ryu JH, Saeki T, Schleinitz N, Shimatsu A, Shimosegawa T, Takahashi H, Takahira M, Tanaka A, Topazian M, Umehara H, Webster GJ, Witzig TE, Yamamoto M, Zhang W, Chiba T, Stone JH； Second International Symposium on IgG4-Related Disease. International consensus guidance statement on the management and treatment of IgG4-related disease. Arthritis Rheumatol. 67(7): 1688-99, 2015
  8. Kawano M, Saeki T. IgG4-related kidney disease-an update. Curr Opin Nephrol Hypertens. 24(2): 193-201, 2015

和文論文

  1. 原　怜史・川野　充弘，細胞性免疫 (Th1, Th17, Treg, mTOR) による腎障害と腎表現型，腎と透析　78（5）：670-7，2015
  2. 原　怜史・梅山　一大・横尾　隆・長嶋　比呂志・長田　道夫，糖尿病性腎症の病理と基礎研究の最前線　実験的糖尿病性腎症（大動物），腎と透析　増刊号　：124-30，2015
  3. 鈴木　康倫，第13回シェーグレン症候群シンポジウム報告，リウマチ科　54（3）：358，2015
  4. 原　怜史・井上　大・井上　康一・川野　充弘，IgG4関連疾患と腎・泌尿器疾患　IgG4関連疾患の腎病変，腎臓内科・泌尿器科　2（3）：298-306，2015
  5. 川野　充弘・水島　伊知郎・山田　和徳・谷口　義典・佐伯　敬子，IgG4関連腎臓病　診断と治療，日本臨床免疫学会会誌　38（1）：8-16，2015
  6. 川野　充弘，特集「IgG4関連疾患の病因・病態を考える」3）IgG4関連腎臓病から，分子リウマチ治療　9（1）：8-12，2015
  7. 川野　充弘・水島　伊知郎・能登原　憲司，特集　全身性疾患としてのIgG4関連疾患　IgG4関連疾患の臨床を知る　IgG4関連後腹膜線維病と大動脈周囲炎，Modern Physician　35（11）：1347-50，2015
  8. 水島　伊知郎・川野　充弘，臓器特異的自己免疫疾患　自己免疫性腎・尿路疾患　IgG4関連腎臓病，日本臨牀　別冊　34（1）：450-4，2015
  9. 鈴木　康倫・藤井　博・山田　和徳・川野　充弘，病気のリーフレット，北陸リウマチ膠原病支援ネットワークパンフレット
  10. 長谷川　徹・山田　和徳，オフィスウロロジー : オフィスウロロジーにおけるマネジメントとマーケティング　Part4　〜血尿の診断の進め方〜，日本泌尿器科学会　2015年　卒後教育テキスト　20（1）：87-94，2015

2014年

欧文論文

  1. Ito N, Yagi K, Kawano M, Mori Y, Okazaki S, Chujo D, Takeda Y, Kobayashi J, Yamagishi M. Analysis of pancreatic endocrine function in patients with IgG4-related diseases, in whom autoimmune pancreatitis was ruled out by diagnostic imaging. Endocr J. 61: 765-72, 2014
  2. Kihara M, Ito K, Nakata J, Otani M, Tran NL, Morito N, Takahashi S, Wada Y, Izui S. O-linked glycocylation determines the nephritogenic potential of IgA rheumatoid factor. J Am Soc Nephrol. 25: 1282-90, 2014
  3. Ito K, Furukawa J, Yamada K, Tran NL, Shinohara Y, Izui S. Lack of galactosylation enhances the pathogenic activity of IgG1 but not IgG2a anti-erythrocyte autoantibodies. J Immunol. 192: 581-8, 2014
  4. Saeki T, Kawano M. IgG4-related kidney disease. Kidney Int. 85: 251-7, 2014
  5. Hamano R, Baba T, Sasaki S, Tomaru U, Ishizu A, Kawano M, Yamagishi M, Mukaida N. Ag and IL-2 immune complexes efficiently expand Agspecific Treg cells that migrate in response to chemokines and reduce localized immune responses. Eur J Immunol. 44: 1005-15, 2014
  6. Aga M, Kondo S, Yamada K, Wakisaka N, Yagi-Nakanishi S, Tsuji A, Endo K, Murono S, Ito M, Muramatsu M, Kawano M, Yoshizaki T. Immunoglobulin class switching to IgG4 in Warthin tumor and analysis of serum IgG4 levels and IgG4-positive plasma cells in the tumor. Hum Pathol. 45: 793-801, 2014
  7. Umehara H, Nakajima A, Nakamura T, Kawanami T, Tanaka M, Dong L, Kawano M. IgG4-related disease(IgG4-RD)and its pathogenesis-cross-talk between Innate and Acquired immunity. Int Immunol. 26: 585-95, 2014
  8. Mizushima I, Inoue D, Yamamoto M, Yamada K, Saeki T, Ubara Y, Matsui S, Masaki Y, Wada T, Kasashima S, Harada K, Takahashi H, Notohara K, Nakanuma Y, Umehara H, Yamagishi M, Kawano M. Clinical course after corticosteroid therapy in IgG4-related aortitis/periaortitis and periarteritis: a retrospective multicenter study. Arthritis Res Ther. 16: R156, 2014
  9. Hara S, Umeyama K, Yokoo T, Nagashima H, Nagata M. Diffuse glomerular nodular lesions in diabetic pigs carrying a dominant-negative mutant hepatocyte nuclear 1-alpha, an inheritant diabetic gene in humans. PLoS One 9: e92219, 2014
  10. Sakamoto K, Ueno T, Kobayashi N, Hara S, Takashima Y, Pasan I, Matsusaka T, Nagata M. The direction and role of phenotypic transition between podocytes and parietal epithelial cells in focal segmental glomerulosclerosis. Am J Physiol Renal Physiol. 306: F98-F104, 2014

和文論文

  1. 川野　充弘・佐伯　敬子，IgG4関連疾患と腎臓病の研究の流れ　国際的な研究の流れと日本の立場，IgG4関連腎臓病のすべて　：12-5，2014
  2. 川野　充弘，IgG4関連腎臓病診療指針，IgG4関連腎臓病のすべて　：16-24，2014
  3. 山口　裕・川野　充弘，病理組織　尿細管間質所見，IgG4関連腎臓病のすべて　：67-71，2014
  4. 佐伯　敬子・川野　充弘，治療と予後，IgG4関連腎臓病のすべて　：98-104，2014
  5. 川野　充弘・山口　裕，IgG4関連腎臓病と鑑別すべき疾患　Sjogren症候群，IgG4関連腎臓病のすべて　：141-5，2014
  6. 井上　亮・金　華恵・覚知　泰志・相木　一秀，肺炎症性偽腫瘍（炎症性筋線維芽細胞腫）を合併した関節リウマチ患者の1例，中部リウマチ　44：39-41，2014
  7. 鈴木　康倫・川野　充弘，多核巨細胞を伴う肉芽腫が目立ったMPO-ANCA関連血管炎の1例. 多核巨細胞性動脈炎はMPO-ANCA血管炎として例外なのか？　腎生検からここまで解る臨床病態50症例　：153，2014
  8. 鈴木　康倫・藤井　博・川野　充弘，Sjogren症候群の病態up to date，リウマチ科　52（3）：326-31，2014
  9. 水島　伊知郎・川野　充弘，Neuromyelitis optic（a視神経脊髄炎）とリウマチ性疾患，リウマチ科　52（5）：490，2014

↑